Latest News

New Insight Into ‘Demon’ Facial Visual Perception Disorder


 

Eye-Opening Findings

The patient described the visual facial distortions as “severely stretched features, with deep grooves on the forehead, cheeks, and chin.” Even though these faces were distorted, he was able to recognize the people he saw.

Because the patient reported no distortion when viewing facial images on a screen, researchers asked him to compare what he saw when he looked at the face of a person in the room to a photograph of the same person on a computer screen.

The patient alternated between observing the in-person face, which he perceived as distorted, and the photo on the screen, which he perceived as normal.

Researchers used real-time feedback from the patient and photo-editing software to manipulate the photo on the screen until the photo and the patient’s visual perception of the person in the room matched.

“This is the first time we have actually been able to have a visualization where we are really confident that that’s what someone with PMO is experiencing,” said Dr. Duchaine. “If he were a typical PMO case, he would look at the face in real life and look at the face on the screen and the face on the screen would be distorting as well.”

The researchers discovered that the patient’s distortions are influenced by color; if he looks at faces through a red filter, the distortions are greatly intensified, but if he looks at them through a green filter, the distortions are greatly reduced. He now wears green-filtered glasses in certain situations.

Dr. Duchaine hopes this case will open the eyes of clinicians. “These sorts of visual distortions that your patient is telling you about are probably real, and they’re not a sign of broader mental illness; it’s a problem limited to the visual system,” he said.

The research was funded by the Hitchcock Foundation. The authors reported no relevant conflicts of interest.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Motor abnormalities drive decreased function in schizophrenia
MDedge Neurology
FDA panel rejects pimavanserin for Alzheimer’s psychosis
MDedge Neurology
Baseline neuromotor abnormalities persist in schizophrenia
MDedge Neurology
Patients with schizophrenia may be twice as likely to develop dementia
MDedge Neurology
Psychiatric illnesses share common brain network
MDedge Neurology
Immunodeficiencies tied to psychiatric disorders in offspring
MDedge Neurology
Visual hallucinations: Differentiating psychiatric and neurologic causes
MDedge Neurology
Cognitive remediation training reduces aggression in schizophrenia
MDedge Neurology
Antipsychotic cuts Alzheimer’s-related agitation
MDedge Neurology
Brain volume patterns vary across psychiatric disorders
MDedge Neurology